Evolve Private Wealth’s Labcorp LH Stock Holding History

Evolve Private Wealth’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,686	Closed	-$450K	–	1143
2026 Q1	$450K	Buy	1,686 +716	+74%	+$194K	0.02%	622
2025 Q4	$243K	Buy	+970	New	+$258K	0.01%	806

Other funds holding LH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Evolve Private Wealth's LH Position: Q2 2026 in Review

Evolve Private Wealth sold out of Labcorp (LH) in Q2 2026, closing a stake of 1,686 shares — an estimated $450K sold.

Evolve Private Wealth first reported a position in LH in Q4 2025 and held it in 2 quarters. The position peaked at $450K in Q1 2026. 1,060 funds tracked by Wall St. Rank hold LH as of Q2 2026.

Evolve Private Wealth reported no remaining Labcorp position as of Q2 2026 after selling out during the quarter.
Evolve Private Wealth sold 1,686 Labcorp shares in Q2 2026, an estimated $450K.
Evolve Private Wealth first reported a position in Labcorp in Q4 2025 and held it in 2 quarters.
Evolve Private Wealth's Labcorp position peaked at $450K in Q1 2026.
1,060 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Evolve Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.